CRDFCardiff Oncology, Inc.vs its industry peers
A metric-by-metric comparison of Cardiff Oncology, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRDFEsta | $102M#6 | — | 3.8x#9 | 171.9x#3 | -13.2%#2 | -0.9%#5 | -8256.3%#3 | -0.2%#3 | — | — | -34.8%#2 | — |
| TNYA | $149M#2 | — | 2.2x#6 | — | — | 18.5%#4 | — | -130.5%#9 | — | — | — | — |
| NMRA | $147M#3 | — | 3.3x#8 | — | — | -2.8%#6 | — | 532.2%#1 | -594.0%#2 | — | — | — |
| LENZ | $130M#4 | — | 0.6x#2 | 6.8x#2 | — | -65.0%#7 | -477.5%#2 | -37.5%#5 | — | — | -90.2%#4 | — |
| ENGN | $127M#5 | 0.8x#1 | 0.6x#1 | — | — | -112.7%#9 | — | -50.9%#6 | — | — | -69.6%#3 | — |
| CGTX | $101M#7 | — | 3.1x#7 | — | — | 30.9%#3 | — | -71.1%#7 | — | — | — | — |
| SCTX | $615M#1 | — | — | — | — | — | — | — | — | — | — | — |
| VXRT | $80M#8 | 2.0x#2 | 1.0x#3 | 0.3x#1 | 726.7%#1 | 124.4%#1 | 7.6%#1 | 0.0%#2 | 22.5%#1 | — | -24.0%#1 | — |
| KLRS | $76M#9 | — | 1.3x#4 | 463.1x#4 | — | 37.2%#2 | -27970.9%#4 | -75.3%#8 | — | — | — | — |
| ELOX | $75M#10 | 5.2x#3 | 1.6x#5 | — | -100.0%#3 | -90.7%#8 | — | -12.9%#4 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice